What does CUSIP 21833P103 represent in this 13F holders report?

CUSIP 21833P103 is the security identifier for CRBP - CORBUS PHARMACEUTICALS HLDGS - COM used to aggregate holder disclosures.

How many institutions held CRBP - CORBUS PHARMACEUTICALS HLDGS - COM in Q2 2018?

77 institutional investors reported CRBP - CORBUS PHARMACEUTICALS HLDGS - COM for Q2 2018. Use the holders table for investor-level position and value details.

CORBUS PHARMACEUTICALS HLDGS - COM (CRBP)

CUSIP: 21833P103

Q2 2018 13F Holders as of 30 Jun 2018

Security type / class: Equity / COM
Total 13F shares: 22,567,367
Total 13F value: $114,259,639
Share change: +1,477,423
Put/Call ratio: 264%
SEC-reported price per share: $5.05
Number of holders: 77
Value change: +$7,134,149
Number of buys: 44
Number of sells: 28

Security key

21833P103

Report period

Q2 2018

Institutions

Top holders

CRBP full security history Ownership snapshot Full 13F holder table Corbus Pharmaceuticals Holdings, Inc. SEC filings Corbus Pharmaceuticals Holdings, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of CRBP - CORBUS PHARMACEUTICALS HLDGS - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

FMR LLC

Disclosed value leader

FMR LLC

Comparable rows

0/15

Latest evidence

31 Mar 2018

13F Highest disclosed value: $26,762,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

FMR LLC has the largest disclosed position value at $26.76M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens FMR LLC's linked filing trail.

Disclosed position value Top 5

FMR LLC $26.76M

Knoll Capital Management, LLC $23.53M

BlackRock Finance, Inc. $22.26M

ETF MANAGERS GROUP, LLC $14.5M

VANGUARD GROUP INC $13.18M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
FMR LLC	13F Company 13F	— denominator unverified	$26,762,000 4,387,188 shares	—	31 Mar 2018
Knoll Capital Management, LLC	13F Company 13F	— denominator unverified	$23,528,000 3,856,985 shares	—	31 Mar 2018
BlackRock Finance, Inc.	13F Company 13F	— denominator unverified	$22,257,000 3,648,579 shares	—	31 Mar 2018
ETF MANAGERS GROUP, LLC	13F Company 13F	— denominator unverified	$14,496,000 2,456,921 shares	—	31 Mar 2018
VANGUARD GROUP INC	13F Company 13F	— denominator unverified	$13,184,000 2,161,309 shares	—	31 Mar 2018
IFP Advisors, Inc	13F Company 13F	— denominator unverified	$7,106,000 1,000,805 shares	—	31 Mar 2018

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2018

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

22,567,367

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2018 vs Q1 2018 Across Filers

Q1 2018 holders

Q2 2018 holders

Holder diff

Investor	Q1 2018 Shares	Q2 2018 Shares	Share Diff	Share Chg %	Q1 2018 value	Q2 2018 value	Value change	Value Chg %